Identification of pathologically favorable disease in intermediate‐risk prostate cancer patients: Implications for active surveillance candidates selection
暂无分享,去创建一个
F. Montorsi | T. Schlomm | M. Graefen | N. Fossati | G. Gandaglia | A. Briganti | F. Chun | M. Moschini | N. Suardi | J. Schiffmann